301 related articles for article (PubMed ID: 18437540)
1. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.
Muraoka-Cook RS; Feng SM; Strunk KE; Earp HS
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):235-46. PubMed ID: 18437540
[TBL] [Abstract][Full Text] [Related]
2. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.
Jones FE
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):247-58. PubMed ID: 18473151
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation.
Muraoka-Cook RS; Sandahl M; Hunter D; Miraglia L; Earp HS
Mol Endocrinol; 2008 Oct; 22(10):2307-21. PubMed ID: 18653779
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland.
Paatero I; Seagroves TN; Vaparanta K; Han W; Jones FE; Johnson RS; Elenius K
J Biol Chem; 2014 Aug; 289(32):22459-69. PubMed ID: 24966332
[TBL] [Abstract][Full Text] [Related]
5. ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo.
Muraoka-Cook RS; Sandahl MA; Strunk KE; Miraglia LC; Husted C; Hunter DM; Elenius K; Chodosh LA; Earp HS
Mol Cell Biol; 2009 Sep; 29(18):4935-48. PubMed ID: 19596786
[TBL] [Abstract][Full Text] [Related]
6. The role of NRG3 in mammary development.
Howard BA
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):195-203. PubMed ID: 18418701
[TBL] [Abstract][Full Text] [Related]
7. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.
Rokicki J; Das PM; Giltnane JM; Wansbury O; Rimm DL; Howard BA; Jones FE
Mol Cancer; 2010 Jun; 9():150. PubMed ID: 20550710
[TBL] [Abstract][Full Text] [Related]
8. The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.
Feng SM; Sartor CI; Hunter D; Zhou H; Yang X; Caskey LS; Dy R; Muraoka-Cook RS; Earp HS
Mol Endocrinol; 2007 Aug; 21(8):1861-76. PubMed ID: 17505063
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
[TBL] [Abstract][Full Text] [Related]
10. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
[TBL] [Abstract][Full Text] [Related]
11. ErbB4 signaling during breast and neural development: novel genetic models reveal unique ErbB4 activities.
Jones FE; Golding JP; Gassmann M
Cell Cycle; 2003; 2(6):555-9. PubMed ID: 14504474
[TBL] [Abstract][Full Text] [Related]
12. Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.
Wali VB; Haskins JW; Gilmore-Hebert M; Platt JT; Liu Z; Stern DF
Mol Cancer Res; 2014 Aug; 12(8):1140-55. PubMed ID: 24829397
[TBL] [Abstract][Full Text] [Related]
13. Role of ErbB4 in breast cancer.
Sundvall M; Iljin K; Kilpinen S; Sara H; Kallioniemi OP; Elenius K
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):259-68. PubMed ID: 18454307
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the mammary gland one cell at a time.
Cristea S; Polyak K
Nat Commun; 2018 Jun; 9(1):2473. PubMed ID: 29946144
[TBL] [Abstract][Full Text] [Related]
15. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5.
Long W; Wagner KU; Lloyd KC; Binart N; Shillingford JM; Hennighausen L; Jones FE
Development; 2003 Nov; 130(21):5257-68. PubMed ID: 12954715
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin: role in mammary gland development and breast cancer.
McBryan J; Howlin J; Napoletano S; Martin F
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):159-69. PubMed ID: 18398673
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.
Pitfield SE; Bryant I; Penington DJ; Park G; Riese DJ
Oncol Res; 2006; 16(4):179-93. PubMed ID: 17120616
[TBL] [Abstract][Full Text] [Related]
18. Mammary gland growth factors: roles in normal development and in cancer.
Hynes NE; Watson CJ
Cold Spring Harb Perspect Biol; 2010 Aug; 2(8):a003186. PubMed ID: 20554705
[TBL] [Abstract][Full Text] [Related]
19. Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1.
Muraoka-Cook RS; Caskey LS; Sandahl MA; Hunter DM; Husted C; Strunk KE; Sartor CI; Rearick WA; McCall W; Sgagias MK; Cowan KH; Earp HS
Mol Cell Biol; 2006 Sep; 26(17):6412-24. PubMed ID: 16914727
[TBL] [Abstract][Full Text] [Related]
20. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.
Stern DF
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):215-23. PubMed ID: 18454306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
